Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-2.92%
-2.08%
-3.34%
+9.79%
-19.01%
SAP
SAP
$302.86
Chart
$250.72 (+20.80%)
$276.8 (+9.41%)
$275.37 (+9.98%)
$187.82 (+61.25%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.92%
-2.08%
-3.34%
+9.79%
-19.01%
SAP
SAP
Current Price
$302.86
Login to view SAP (SAP) recommendation from the last 90 days from financial news and social media.
Chart
$250.72 (+20.80%)
$276.8 (+9.41%)
$275.37 (+9.98%)
$187.82 (+61.25%)
SAP Latest Headlines
Why Is Taysha Gene Therapies Stock Trading Higher On Thursday?. ) on Wednesday announced details of its planned pivotal Part B trial design for TSHA-102 following written alignment from the United States Food .Single-arm open-label trial with patients serving as their control (intend N=15).Enrollment of females in the developmental plateau population of .The primary endpoint will assess developmental milestone gain or regain.The safety of TSHA-102 will be evaluated in females in the pre-developm
Thu May 29, 2025
Why Is Taysha Gene Therapies Stock Trading Higher On Thursday?. ) on Wednesday announced details of its planned pivotal Part B trial design for TSHA-102 following written alignment from the United States Food .Single-arm open-label trial with patients serving as their control (intend N=15).Enrollment of females in the developmental plateau population of .The primary endpoint will assess developmental milestone gain or regain.The safety of TSHA-102 will be evaluated in females in the pre-developm
Thu May 29, 2025
Why Is Taysha Gene Therapies Stock Trading Higher On Thursday?. ) on Wednesday announced details of its planned pivotal Part B trial design for TSHA-102 following written alignment from the United States Food .Single-arm open-label trial with patients serving as their control (intend N=15).Enrollment of females in the developmental plateau population of .The primary endpoint will assess developmental milestone gain or regain.The safety of TSHA-102 will be evaluated in females in the pre-developm
Thu May 29, 2025
SAP part of group in discussions to build German AI data center: report.
Tue May 27, 2025
SAP SE (SAP)s Strategic Pivot Drives Optimism – JPMorgan Reaffirms Overweight Rating.
Tue May 27, 2025
SAP Capgemini Mistral AI Partner To Offer AI Solutions For Regulated Industries. ) generative (gen AI) solutions for regulated industries.This collaboration enables the deployment of tailored AI solutions within SAP systems in a secure trusted environment which is ideal for sectors with stringent data regulations such as financial services public sector aerospace &. defense and energy &. utilities.By combining Mistral AI'.s cutting-edge generative AI models with the SAP Business Tech
Tue May 27, 2025
SAP Capgemini Mistral AI Partner To Offer AI Solutions For Regulated Industries. ) generative (gen AI) solutions for regulated industries.This collaboration enables the deployment of tailored AI solutions within SAP systems in a secure trusted environment which is ideal for sectors with stringent data regulations such as financial services public sector aerospace &. defense and energy &. utilities.By combining Mistral AI'.s cutting-edge generative AI models with the SAP Business Tech
Tue May 27, 2025
SAP Capgemini Mistral AI Partner To Offer AI Solutions For Regulated Industries. ) generative (gen AI) solutions for regulated industries.This collaboration enables the deployment of tailored AI solutions within SAP systems in a secure trusted environment which is ideal for sectors with stringent data regulations such as financial services public sector aerospace &. defense and energy &. utilities.By combining Mistral AI'.s cutting-edge generative AI models with the SAP Business Tech
Tue May 27, 2025
Beyond The Numbers: 4 Analysts Discuss SAP Stock. SAP (NYSE:) has been analyzed by 4 analysts in the last three months revealing a diverse range of perspectives from ish to bearish.The following table summarizes their recent ratings shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.1300002000110000000000000Insights from analysts'. 12-month price targets are revealed presenting an average target of $322.0 a high estimate of $330.00 an
Fri May 23, 2025
SAP Shares Fall As Trump Tariff Threat Spurs Fears For Transatlantic Tech Trade. ) stock fell 1.71% to $294.73 Friday morning part of a broader market selloff triggered by President impose a sweeping 50% tariff on all European Union imports starting June 1. The potential trade barrier reignited fears of a renewed transatlantic trade war sending European equities tumbling.The company'.s cloud-based business model and extensive client base in United States industries such as finance healthcare
Fri May 23, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
